Provided by Tiger Trade Technology Pte. Ltd.

PolyPid Ltd.

5.19
-0.1800-3.35%
Post-market: 5.13-0.0600-1.16%19:30 EDT
Volume:168.31K
Turnover:885.85K
Market Cap:105.42M
PE:-3.52
High:5.55
Open:5.49
Low:5.06
Close:5.37
52wk High:5.73
52wk Low:3.06
Shares:20.31M
Float Shares:12.51M
Volume Ratio:2.38
T/O Rate:1.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4762
EPS(LYR):-2.0900
ROE:-243.59%
ROA:-74.63%
PB:19.57
PE(LYR):-2.48

Loading ...

PolyPid - FDA Acceptance Triggers $15 Mln Milestone Payment, Completing $30 Mln in Payments

THOMSON REUTERS
·
Jul 29

PolyPid Announces FDA Acceptance of Nda with Priority Review for D-Plex₁₀₀

THOMSON REUTERS
·
Jul 29

PolyPid price target lowered to $12 from $13 at Craig-Hallum

TIPRANKS
·
Jul 22

Roth says Azurity deal validates D-PLEX100, sees limited near-term revenue

TIPRANKS
·
Jul 22

Polypid Price Target Maintained with a $13.00/share by HC Wainwright & Co.

Dow Jones
·
Jul 22

Polypid Partners with Azurity to Commercialize D-plex100 in US, Canada

Reuters
·
Jul 21

Polypid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-plex₁₀₀ in the U.S. and Canada

THOMSON REUTERS
·
Jul 21

Polypid - U.S. Launch of D-plex100 Targeted for Q1 2027

THOMSON REUTERS
·
Jul 21

Polypid - to Receive $15 Mln Upfront and $15 Mln on FDA Nda Acceptance

THOMSON REUTERS
·
Jul 21

Polypid - to Receive over $320 Mln in Payments Plus Tiered Royalties

THOMSON REUTERS
·
Jul 21

Polypid Says it Could Receive More than $320 Million in Upfront and Milestone Payments

THOMSON REUTERS
·
Jul 21

Israel's Polypid, Azurity Pharmaceuticals Sign Commercialisation Deal for D-plex100 Drug to Prevent Surgical Site Infections

THOMSON REUTERS
·
Jul 21

Polypid Sets 5,012,403-share Option Pool Under Amended 2012 Equity Plan

Reuters
·
Jul 16

Lilly’s $780M Bet is Reshaping Surgical Infection Prevention, and PolyPid’s Asset is Hiding in Plain Sight

TIPRANKS
·
Jun 26

PolyPid Sets July 15, 2026 Shareholder Meeting to Vote on Board, Auditor and Equity Grants

TIPRANKS
·
Jun 11

PolyPid announces shareholder meeting notice

Reuters
·
Jun 11

PolyPid submits D-PLEX100 NDA to FDA under rolling review

Reuters
·
Jun 01

PolyPid - FDA Decision on D-Plex100 Expected in Q1 2027 Under Pdufa Timeline

THOMSON REUTERS
·
Jun 01

PolyPid Completes New Drug Application Submission to FDA for D-Plex₁₀₀

THOMSON REUTERS
·
Jun 01

PolyPid management attends Craig-Hallum institutional investor conference investor meetings

Reuters
·
May 20